EUVIMEDEUVIMED entdecken
Crossref

iRGD-NaGd(MoO 4 ) 2 : A Tumor-Targeted Magnetic Resonance Contrast Agent Activating Immunotherapy via the cGAS-STING Pathway

Ling Yu, Fengkai Qiu, Yumin Hu, Tingting Liao, Mengqian Zhai, Ronghua Wu, Qianhui He, Huilin Hu, Shuiwei Xia, Junguo Hui, Zufei Wang, Yang Yang und 6 weitere

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c03469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Ling Yu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biote…. Hauptthemen laut MEDLINE: Immunotherapy, Contrast Media, Membrane Proteins, Nucleotidyltransferases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Science and Technology Department of Zhejiang Province, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyContrast MediaMembrane ProteinsNucleotidyltransferasesNeoplasmsAnimalsMagnetic Resonance ImagingMiceHumansNanoparticlesCell Line, TumorSignal TransductionGadoliniumSTING Protein

Stichwörter der Autor:innen

MRI contrast agentcGAS-STING pathwayimmunotherapyintegration of diagnosis and treatmenttumor targeting

Substanzen

Contrast MediaMembrane ProteinsNucleotidyltransferasesGadoliniumSTING1 protein, humanSTING Protein

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Center of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical University,…
  • Department of Radiology, Lishui Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China.
  • Clinical College of the Affiliated Central Hospital, School of Medicine, Lishui University, Lishui 323000, China.
  • Key Laboratory of Precision Medicine of Lishui, Lishui Central Hospital, Lishui 323000, China.

ORCID-Profile: Jiansong Ji

Förderung

  • Science and Technology Department of Zhejiang Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Lishui Innovation Consortium-Key Research and development Program Projects
  • Zhejiang Medicine and Health science and Technology Project

Zitieren

APA

Yu, L., Qiu, F., Hu, Y., Liao, T., Zhai, M., Wu, R., He, Q., Hu, H., Xia, S., Hui, J., Wang, Z., Yang, Y., Qiu, R., Chen, M., Chen, W., Tu, J., Ji, J., & Lu, C. (2025). iRGD-NaGd(MoO 4 ) 2 : A Tumor-Targeted Magnetic Resonance Contrast Agent Activating Immunotherapy via the cGAS-STING Pathway. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c03469

Vancouver

Yu L, Qiu F, Hu Y, Liao T, Zhai M, Wu R, et al. iRGD-NaGd(MoO 4 ) 2 : A Tumor-Targeted Magnetic Resonance Contrast Agent Activating Immunotherapy via the cGAS-STING Pathway. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c03469

BibTeX
@article{Yu2025,
  author = {Yu, Ling and Qiu, Fengkai and Hu, Yumin and Liao, Tingting and Zhai, Mengqian and Wu, Ronghua and He, Qianhui and Hu, Huilin and Xia, Shuiwei and Hui, Junguo and Wang, Zufei and Yang, Yang and Qiu, Rongfang and Chen, Minjiang and Chen, Weiqian and Tu, Jianfei and Ji, Jiansong and Lu, Chenying},
  title = {iRGD-NaGd(MoO 4 ) 2 : A Tumor-Targeted Magnetic Resonance Contrast Agent Activating Immunotherapy via the cGAS-STING Pathway},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c03469}
}
Kostenlos starten →